Eusol Biotech Co.,Ltd. (6652.TWO)
TWD 6.04
(-0.17%)
TWD 6.04
(-0.17%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 410.25 Million TWD | -6.93% |
| 2022 | 440.81 Million TWD | -3.1% |
| 2021 | 454.91 Million TWD | 61.83% |
| 2020 | 281.1 Million TWD | -28.36% |
| 2019 | 392.4 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 395.92 Million TWD | 0.0% |
| 2024 Q1 | 395.92 Million TWD | -3.49% |
| 2023 Q4 | 410.25 Million TWD | 0.0% |
| 2023 FY | 410.25 Million TWD | -6.93% |
| 2023 Q3 | 410.25 Million TWD | -4.29% |
| 2023 Q2 | 428.66 Million TWD | 0.0% |
| 2023 Q1 | 428.66 Million TWD | -2.76% |
| 2022 Q4 | 440.81 Million TWD | 0.0% |
| 2022 FY | 440.81 Million TWD | -3.1% |
| 2022 Q3 | 440.81 Million TWD | 0.0% |
| 2021 FY | 454.91 Million TWD | 61.83% |
| 2020 FY | 281.1 Million TWD | -28.36% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 85.858% |
| Level Biotechnology Inc. | 822.67 Million TWD | 50.131% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 38.281% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 25.237% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 89.464% |
| GlycoNex Incorporation | 1.55 Billion TWD | 73.58% |
| VBI | 452.1 Million TWD | 9.255% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 65.118% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 45.195% |
| Visgeneer Inc. | 397.17 Million TWD | -3.294% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 89.119% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 80.998% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 53.543% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 93.266% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -457.734% |
| Enimmune corporation | 604.82 Million TWD | 32.169% |
| TaiRx, Inc. | 833.74 Million TWD | 50.793% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 86.706% |
| EirGenix Inc. | 11.16 Billion TWD | 96.325% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 28.419% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 76.041% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 88.594% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 60.946% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -36.284% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -55.015% |
| Lukas Biomedical Inc. | 441.19 Million TWD | 7.011% |
| RBC Bioscience Corporation | 753.79 Million TWD | 45.574% |
| BiOptic Inc. | 613.77 Million TWD | 33.158% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 76.935% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 64.624% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 36.379% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 86.793% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -220.396% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -8.43% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 63.817% |
| Neith Corporation | 192.15 Million TWD | -113.506% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -177.325% |
| NaviFUS Corp. | 490.53 Million TWD | 16.365% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 66.529% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 69.909% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 22.468% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 64.675% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 75.23% |
| AP Biosciences Inc | 890.75 Million TWD | 53.943% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 95.189% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -26.565% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 69.238% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 84.867% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 97.33% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -3.378% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 80.237% |
| TCI GENE Inc. | 1.16 Billion TWD | 64.813% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -39.268% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 69.908% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 56.437% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 41.262% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 89.624% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 89.268% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 66.641% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 92.679% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 61.37% |
| Acepodia, Inc. | 6.81 Billion TWD | 93.983% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 89.279% |